EPG Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$626K Buy
7,225
+162
+2% +$15.5K 0.17% 132
2025
Q4
$679K Buy
7,063
+154
+2% +$15K 0.18% 125
2025
Q3
$658K Buy
6,909
+231
+3% +$21.2K 0.18% 132
2025
Q2
$582K Buy
6,678
+3
+0% +$254 0.17% 134
2025
Q1
$600K Buy
6,675
+460
+7% +$41.2K 0.17% 149
2024
Q4
$496K Sell
6,215
-38
-0.6% -$3.29K 0.13% 162
2024
Q3
$563K Buy
+6,253
New +$526K 0.14% 154
2024
Q2
Sell
-7,427
Closed -$609K 152
2024
Q1
$647K Buy
7,427
+137
+2% +$11.7K 0.16% 152
2023
Q4
$609K Buy
7,290
+545
+8% +$41.5K 0.16% 148
2023
Q3
$529K Buy
+6,745
New +$565K 0.16% 144
2020
Q2
Sell
-802
Closed -$72K 517
2020
Q1
$72K Buy
802
+408
+104% +$43.4K 0.05% 225
2019
Q4
$45K Buy
+394
New +$43.2K 0.03% 249

Other funds holding MDT

EPG Wealth Management's MDT Position: Q1 2026 in Review

EPG Wealth Management increased its Medtronic (MDT) stake by 2.3% in Q1 2026, buying an estimated $15.5K and bringing the position to 7,225 shares worth $626K. The position accounts for 0.17% of the portfolio, ranked #132.

EPG Wealth Management first reported a position in MDT in Q4 2019 and has held it in 12 quarters since. The position peaked at $679K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • EPG Wealth Management held 7,225 shares of Medtronic worth $626K as of Q1 2026.
  • EPG Wealth Management bought 162 Medtronic shares in Q1 2026, an estimated $15.5K.
  • Medtronic made up 0.17% of EPG Wealth Management's portfolio in Q1 2026, its #132 holding.
  • EPG Wealth Management first reported a position in Medtronic in Q4 2019 and has held it in 12 quarters since.
  • EPG Wealth Management's Medtronic position peaked at $679K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on EPG Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.